Table 2 Distribution of the characteristics of PSIH before the pandemic and at present
Pre-pandemic (n = 63) | Present-day (n = 25) | ||||
|---|---|---|---|---|---|
Characteristics of PSIHs | n (%) | CI95% | n (%) | CI95% | P-value |
Avoidability | |||||
Avoidable | 39 (61.9%) | 49.9–73.9% | 13 (52%) | 32.4–71.6% | 0.394 |
Non-avoidable | 24 (38.1%) | 26.1–50.1% | 12 (48%) | 28.4–67.6% | |
Harm severity | |||||
Mild | 32 (50.8%) | 38.4–63.1% | 12 (48%) | 28.4–67.6% | 0.484 |
Moderate | 24 (38.1%) | 26.1–50.1% | 12 (48%) | 28.4–67.6% | |
Severe | 7 (11.1%) | 3.4–18.9% | 1 (4%) | 0.1–11.7% | |
Place of occurrence | |||||
Primary care setting | |||||
Healthcare centre | 21 (33.3%) | 21.7–45.0% | 6 (24%) | 7.3–40.7% | 0.469 |
Patient’s home | 14 (22.2%) | 12.0–32.5% | 4 (16%) | 1.6–30.4% | |
Healthcare handover | 11 (17.5%) | 8.1–26.8% | 6 (24%) | 7.3–40.7% | |
Subtotal | 46 (73.0%) | 62.1–84.0% | 16 (64%) | 45.2–82.8% | |
Others | |||||
Hospital | 15 (23.8%) | 13.3–34.3% | 6 (24%) | 7.3–40.7% | |
Socio-health services centre | 2 (3.2%) | 0.1–7.5% | 3 (12%) | 0.1–24.7% | |
Subtotal | 17 (27.0%) | 16.0–37.9% | 9 (36%) | 17.2–54.8% | |
Nature | |||||
Prescription error | 21 (33.3%) | 21.7–45.0% | 5 (20%) | 4.3–35.7% | 0.128 |
Drug administration error by patient | 18 (28.6%) | 17.4–39.7% | 5 (20%) | 4.3–35.7% | |
Therapeutic procedure | 9 (14.3%) | 5.6–22.9% | 4 (16%) | 1.6–30.4% | |
Diagnostic error | 4 (6.3%) | 0.3–12.4% | 5 (20%) | 4.3–35.7% | |
Diagnostic test | 3 (4.8%) | 0.1–10.0% | 0 (0%) | 0–0% | |
Follow-up and care | 6 (9.5%) | 2.3–16.8% | 5 (20%) | 4.3–35.7% | |
Others | 2 (3.2%) | 0.1–7.5% | 1 (4%) | 0.1–11.7% | |